Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dl-cycloserine
2. 68-39-3
3. 4-amino-1,2-oxazolidin-3-one
4. 4-amino-3-isoxazolidinone
5. Dl-4-aminoisoxazolidin-3-one
6. 3-isoxazolidinone, 4-amino-
7. Rac Cycloserine
8. 4-amino-3-isoxazolidone
9. Dl-4-amino-3-isoxazolidinone
10. Nsc154851
11. 3-isoxazolidinone, D-
12. 4-amino-4,5-dihydro-1,2-oxazol-3-ol
13. 3-isoxazolidinone, (r)-
14. 3-isoxazolidinone, (+)-
15. Wln: T5omvj Dz -d
16. Cycloserine, D-
17. .alpha.-cycloserine
18. (+-)-4-amino-3-isoxazolidinone
19. (+-)-oxamicina [italian]
20. (+-)-oxamicina
21. Einecs 200-687-9
22. (+-)-4-amino-3-isossazolidone [italian]
23. Ai3-61058
24. Mfcd00005353
25. (+-)-4-amino-3-isossazolidone
26. 3-isoxazolidinone, 4-amino-, (+-)-
27. Mfcd00064323
28. 3-isoxazolidinone,4-amino-, (4r)-
29. 4-amino-isoxazolidin-3-on
30. Dl-cycloserine, Crystalline
31. 4-amino-isoxazolidin-3-one
32. Lopac0_000267
33. Schembl34323
34. 4-amino-2-isoxazoline-3-ol
35. 4-amino-3-isoxazolidinone #
36. Chebi:23503
37. Dtxsid40859074
38. Hms3260f16
39. Hms3370d10
40. Hms3374e09
41. Hms3393c15
42. Pharmakon1600-01506178
43. Act10891
44. Bcp22967
45. Bcp22968
46. Nsc76029
47. Tox21_500267
48. (+/-)-3-oxoisooxazolidin-4-amine
49. Bbl016489
50. Nsc760409
51. Stk177281
52. Stl454326
53. Akos005410669
54. Ccg-204362
55. Cs-w008440
56. Lp00267
57. Sb23044
58. Sdccgsbi-0050255.p002
59. Ncgc00015213-04
60. Ncgc00015213-05
61. Ncgc00015213-06
62. Ncgc00015213-07
63. Ncgc00015213-08
64. Ncgc00015213-11
65. Ncgc00093725-01
66. Ncgc00093725-02
67. Ncgc00093725-03
68. Ncgc00093725-04
69. Ncgc00260952-01
70. Bp-20174
71. Ds-18396
72. Sy005636
73. Db-055147
74. Db-055151
75. Db-068913
76. Am20100628
77. Eu-0100267
78. Ft-0624464
79. Ft-0631297
80. Ft-0665409
81. Ft-0696808
82. O-isobutyl (3,4-dichlorophenyl)carbamothioate
83. C 7005
84. C06682
85. 064c323
86. A855990
87. A858006
88. Sr-01000075776
89. Sr-01000075776-1
90. W-104673
91. Q27109800
92. Cycloserine; Seromycin; Orientomycin; Oxamycin; Seromycin
93. (s)-4-amino-3-isoxazolidone; (s)-cycloserine;levcycloserine
| Molecular Weight | 102.09 g/mol |
|---|---|
| Molecular Formula | C3H6N2O2 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 102.042927438 g/mol |
| Monoisotopic Mass | 102.042927438 g/mol |
| Topological Polar Surface Area | 64.4 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 92.9 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Dl-Cycloserine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dl-Cycloserine, including repackagers and relabelers. The FDA regulates Dl-Cycloserine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dl-Cycloserine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dl-Cycloserine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dl-Cycloserine supplier is an individual or a company that provides Dl-Cycloserine active pharmaceutical ingredient (API) or Dl-Cycloserine finished formulations upon request. The Dl-Cycloserine suppliers may include Dl-Cycloserine API manufacturers, exporters, distributors and traders.
click here to find a list of Dl-Cycloserine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Dl-Cycloserine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dl-Cycloserine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dl-Cycloserine GMP manufacturer or Dl-Cycloserine GMP API supplier for your needs.
A Dl-Cycloserine CoA (Certificate of Analysis) is a formal document that attests to Dl-Cycloserine's compliance with Dl-Cycloserine specifications and serves as a tool for batch-level quality control.
Dl-Cycloserine CoA mostly includes findings from lab analyses of a specific batch. For each Dl-Cycloserine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dl-Cycloserine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dl-Cycloserine EP), Dl-Cycloserine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dl-Cycloserine USP).
LOOKING FOR A SUPPLIER?
